Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.

导出 OA

翻译打印收藏纠错

第一作者： Timothy R,Smith

第一单位： StudyMetrix Research, LLC, 3862 Mexico Road, St. Peters, MO, 63303, USA. tsmith@studymetrix.com.

作者： Timothy R,Smith ^[1] ; Egilius L H,Spierings ^[2] ; Roger,Cady ^[3] ; Joe,Hirman ^[4] ; Barbara,Schaeffler ^[5] ; Vivienne,Shen ^[6] ; Bjørn,Sperling ^[7] ; Thomas,Brevig ^[7] ; Mette Krog,Josiassen ^[7] ; Elizabeth,Brunner ^[6] ; Loan,Honeywell ^[7] ; Lahar,Mehta ^[5]

作者单位： StudyMetrix Research, LLC, 3862 Mexico Road, St. Peters, MO, 63303, USA. tsmith@studymetrix.com. ^[1] Medvadis Research Corporation, Boston PainCare, Waltham, MA, USA. ^[2] Lundbeck La Jolla Research Center, San Diego, CA, USA. ^[3] Pacific Northwest Statistical Consulting, Inc, Woodinville, WA, USA. ^[4] Lundbeck Seattle BioPharmaceuticals, Inc, Seattle, WA, USA. ^[5] Lundbeck LLC, Deerfield, IL, USA. ^[6] H. Lundbeck A/S, Copenhagen, Denmark. ^[7]

DOI 10.1186/s10194-021-01253-3

PMID 34034644

发布时间 2024-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

The journal of headache and pain

2021年22卷1期

46页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.

The journal of headache and pain

相似文献

The journal of headache and pain

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.

The journal of headache and pain

相似文献

The journal of headache and pain

相关期刊

检索历史清除